Aberrant Promoter Methylation of the Tumour Suppressor RASSF10 and Its Growth Inhibitory Function in Breast Cancer

Breast cancer is the most common cancer in women, with 1.7 million new cases each year. As early diagnosis and prognosis are crucial factors in cancer treatment, we investigated potential DNA methylation biomarkers of the tumour suppressor family Ras-association domain family (RASSF). Promoter hyper...

Descripción completa

Detalles Bibliográficos
Autores principales: Richter, Antje M., Walesch, Sara K., Dammann, Reinhard H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810110/
https://www.ncbi.nlm.nih.gov/pubmed/26927176
http://dx.doi.org/10.3390/cancers8030026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810110/
https://www.ncbi.nlm.nih.gov/pubmed/26927176
http://dx.doi.org/10.3390/cancers8030026

Ejemplares similares